Reports indicating the value of quinidine sulfate in angina pectoris led to (1) a search for related drugs which were equally effective but less toxic, and (2) a study of the mode of action of these drugs. It was found that quinidine, quinine, cinchonadine, and cinchamidine decrease the frequency of attacks in daily life and increase the exercise tolerance as measured by a standardized test. Quinine sulfate (0.3 to 0.4 Gm. every eight hours) appears to be the drug of choice from the standpoint of availability and low toxicity as well as effectiveness. The value of these drugs is apparently due to a vasodilating action which in turn is dependent on the presence of the quinoline ring.
P REVIOUS studies1-6 have demonstrated the value of quinidine sulfate in the treatment of some patients with angina pectoris. However, most general practitioners and, in fact, many cardiologists hesitate to use quinidine in angina because of the complications which occasionally follow its use in the treatment of cardiac arrhythmias. Furthermore, many physicians hesitate to use quinidine in angina pectoris because its mode of action in this condition is not clear. It seemed worthwhile, therefore, to study the activity of drugs related to quinidine in an attempt to find a substance equally effective but possibly less toxic and also to throw some light on the mechanism of action in the treatment of angina pectoris.
The comparative value of 12 pharmaceutical preparations was investigated in patients with angina pectoris. Five of these 12 were cinchona alkaloids (the sulfate salts of quinidine, quinine, cinchonine, cinchonidine, and cinchamidine); these were studied to determine whether drugs which were similar to quinidine in chemical structure synthetic antimalarial preparations (chloroquine, pentaquine and chlorguanide) were chosen to see whether the therapeutic action in angina might be related to the mechanism responsible for antimalarial activity. Nitroglycerin was used to determine which patients were likely to be benefited by vasodilator drugs and also to compare the effectiveness of the cinchona alkaloids with that of nitroglycerin which is the most effective of the drugs for angina. Pentaerythritol tetranitrate (Peritrate) was included to compare the frequency and degree of response of the cinchona alkaloids with that of a preparation currently advocated for the treatment of angina pectoris. Finally, placebos were used for control studies and to equalize the beneficial psychologic effects of treatment.
Evaluation of the efficacy of treatment in angina pectoris is difficult. Some of the many factors and problems involved in evaluating treatment in angina will be summarized elsewhere.7 The methods employed in the present study are based on over 20 years' experience in the Angina Clinic of the Beth Israel Hospital of Boston. In general, these studies are carried out in a group of patients with angina carefully selected for cooperation and a stable clinical course. The methods include clinical evaluation (using what has been called the "double blind test") and, especially, an exercise tolerance test which measures the amount of work which can be done under standardized conditions (in the cold) before angina is inCirculation, Volume duced. In addition, the work electrocardiogram after treatment was compared with that observed after placebos. Furthermore, the results with the drugs being evaluated were compared with those obtained with other medication in current use. In particular, the results were analyzed not only as observed in the entire group of subjects but also in subdivision based on the ability of the patients to respond to nitroglycerin.
MATERIALS AND METHODS Medication
The Cinchona Alkaloids. Cinchona bark contains about 35 alkaloids of which five chemically related compounds are obtained in appreciable amounts during the process of extracting the commercially important quinine. Quinine and quinidine are optical isomers (fig. 1) ; the former is levorotatory (minus 169 degrees) the latter is dextrorotatory (plus 230 degrees). Cinchonine (plus 229 degrees) and cinchonidine (minus 109 degrees) are also optical isomers; these two drugs are similar to quinine and quinidine except for a methoxy group in the quinoline ring. Cinchamidine (minus 98 degrees) is similar to cinchonidine except for the presence of two hydrogen atoms in the side chain.
Quinidine is far more effective in the treatment of the cardiac arrhythmias than the other alkaloids found in cinchona bark8' 9; only four groups of investigators have reported on its use in angina pectoris. '-6 The five cinchona alkaloids used in this studv were prepared in Holland* in the form of 0.12 Gm. (2 grain) scored, compressed, white tablets, identical with each other in appearance. The dosage used in most instances was 0.360 Gm. (6 grains) or three tablets given three times daily; on arising, at 2.00 p.m., and on retiring. This interval was selected because it has been shown that eight hours after the administration of quinidine sulfate, the concentration in the blood12 and the effect on the heart1 are approximately one-half as great as the maximum. Thus, with 0.4 Gm. (6 grains) every eight hours the effective level in the blood is constantly as high as or higher than the maximum obtained with 0.12 Gm. (3 grains) given at four-hour intervals. Several patients who benefited from the 0.4 Gm. dosage were subsequently given smaller amounts in order to determine the minimum effective dose; patients who failed to respond to 0. After the first visit, each patient was given a placebo to be taken three times daily. Observation for several weeks to months established the usual frequency of attacks in daily life and, with some degree of accuracy, the standardized exercise tolerance following placebos. The evaluation of medication was then begun. Further checks of the patients' exercise tolerance while taking placebos was redetermined frequently during the course of the study.
At each visit, after the exercise tolerance had been measured, the patient returned to the original observer. who supplied sufficient medication for the following week. In each instance it was stated or implied that the medication dispensed had been reported as effective in some cases with angina. No definite or constant order of rotation of the drugs was followed except that placebos were invariably given for several weeks before administering any potentially effective medication. If the studies failed to indicate any appreciable benefit, a different medication was prescribed. If the drug was followed by evidence of improvement (i.e., an increase in exercise tolerance of at least 20 per cent as compared with the maximum performed while taking placebos or when taking no medication), a placebo resembling the effective drug was again administered, often (especially with quinine and quinidine) with a different appearance.
Electrocardiographic Studies
After the therapeutic value of the drugs had been determined as above, electrocardiographic studies were carried out in some patients who showed a beneficial result in order to determine if the effect was accompanied by objective evidence of a decrease in myocardial anoxia.18, 25 In order to obtain tracings with a minimum of somatic tremor or wandering of the base line during and immediately after exercise, the arm electrodes were applied just below the insert-on of the deltoids; the leg electrodes were applied over the bony prominence of the iliac crests; a precordial electrode (measuring 212 by 112 inches) was applied in the fifth left intercostal space at the midelavicular line, and the cable was held in the patient's right hand against his body. A direct recording Sanborn Electrocardiograph was used. Lead 4R only, was re.
corded.
Evidence of myocardial anoxia is most frequently and most strikingly shown by this lead because anoxia is associated with RS-T depression in V4 and RS-T elevation in VR while lead 4R is V4 minus VR. Only one lead was recorded on any one day because comparison of tracings before and after medication requires comparison of complexes observed at identical times after exercise.
A 15-second control tracing was taken with the patient standing at rest in the cold room. The exercise was then carried out in the usual manner, but with the electrodes and cable in place and the machine, but not the recording stylus, running constantly. The tracing was recorded immediately before the expected cessation of exercise and for 15 seconds thereafter; the end of exercise was marked. Additional 15 second strips were obtained, one, three, and five minutes after the cessation of exertion. In examining the tracings, the characteristics of 10 consecutive complexes without wandering of the base line were measured and the average obtained.
Before medication (while taking placebos), exercise was continued until a typical attack was induced After medication, exercise was stopped when the patient had performed the same number of trips as had induced angina while taking placebos.
EVALUATION OF RESULTS
Three methods of evaluation were used and their results were correlated with each other. These three methods were: (1) The exercise tolerance; that is, the amount of work which could be performed (under the standardized conditions described above) before angina was precipitated. ( 28 per cent) could do no more work (or less than 20 per cent more work) after the sublingual administration of nitroglycerin than was possible without the drug. The patients' response to nitroglycerin was an index of the likelihood of his response to other effective medication; the results, therefore, are examined accordingly (tables 3 and 5).
Pentaerythritol Tetranitrate. Fourteen patients received 50 mg. of this preparation, four times daily; only three showed objective evidence of a favorable response. All three patients were group 1 subjects; the degree of response was moderate in degree (an increase in exercise tolerance of 20, 28, and 39 per cent, respectively).
Procaine Amide Hydrochloride. Seventeen patients received 750 mg. of this drug, three times daily. Only one showed a beneficial response. Subsequent observation in this patient suggests that this apparent response was due, not to the medication, but rather to a spontaneous partial remission, for her exercise tolerance, even after several months of placebos, had not returned to its original range.
Two of the 17 patients who received procaine amide showed ventricular extrasystoles during their attacks of angina pectoris. The lack of improvement of the angina in these two patients following procaine amide is in contrast to the favorable response reported by patients. A significant increase in exercise tolerance was shown by 18 of the 31 (58 per cent); these patients included 16 of the 22 subjects in groups 1 and 2 (73 per cent). In many instances, the increase in exercise tolerance induced by quinidine persisted for two to three weeks after the drug was withdrawn. This is in contrast with our experience with other drugs such as the purines2' 30 where any improvement usually disappears within one week. Two patients had a complete remission of symptoms: that is, following quinidine therapy they experienced no attacks in daily life, and they were able to exercise until fatigued without developing angina under the usual standardized conditions. In these patients, this remission persisted for at least two months after placebos were substituted for quinidine. In both instances, readministration of quinidine at a later date was again followed by a complete but temporary remission.
Quinine sulfate was given to 29 patients, 3 of whom discontinued the medication. Of the remaining 26, a moderate or marked response was shown by 10 (38 per cent); these 10 were all patients of groups 1 and 2 and constituted 47 per cent of the 21 patients in these two The comparative value of quinine and quinidine is best shown by the 25 patients whose response to both drugs was tested (table 5) . Of these 25 patients, the results in 15 (60 per cent) were identical; four additional patients (16 per cent) showed a response to both drugs but a better response to one than to the other. The remaining six patients (24 per cent), showed a moderate or marked response to one drug but no appreciable response to the other.
Cinchonidine sulfate was administered to 17 patients, one of whom omitted the drug. Of the remaining 16 patients, 7 (44 per cent) showed a moderate or marked response; six of these patients were in group 1 (these six made up 55 per cent of the group 1 and 2 patients who received cinchonidine).
Cinchamidine sulfate was given to 18 patients; nine (50 per cent) had a moderate or marked response. All of these nine were in groups 1 and 2 (64 per cent).
Cinchonine sulfate was given to 20 patients, one of whom discontinued its use. Only four of these patients showed a moderate response; no patient showed a marked response. creased exercise tolerance for six months, and readministration of chlorguanide caused no further increase in ability to exercise.
Electrocardiographic Studies
Electrocardiographic studies were carried out in five patients in groups 1 and 2 while they were taking placebos, nitroglycerin, quinidine, quinine or cinchamidine (table 6, fig. 2 ). The most striking change in lead 4R was observed immediately (within 15 seconds) after the cessation of exercise and consisted of a depression of the RS-T segments; this is in accord with previous studies. 25 In these five patients, nitroglycerin not only prevented attacks of angina, but also decreased markedly the RS-T depression. The average RS-T depression following exercise was 2.1 mm. while taking placebos and 0.65 mm. after nitroglycerin. In general, those who showed the greatest RS-T changes while taking placebos showed the greatest improvement in the exercise electrocardiogram after nitroglycerin. The RS-T depressions of the two patients who benefited from quinidine were 3.5 mm. and 1.5 mm., respectively, while taking placebos, as compared with 1.25 mm. and 1.0 mm., respectively, while taking quinidine. Similarly, the three patients who benefited from quinine showed RS-T depressions of 3.0 mm. 2.0 mm. and 1.5 mm. before, and 2.23 mm. 0.75 mm. and 0.75 mm., respectively, after this drug. The results with cinchamidine, although not so striking, also showed a diminution of the anoxic changes in the exercise electrocardiogram; the RS-T depressions measured 3.0 mm. 1.5 mm. and 0.5 mm. following placebos and 2.0 mm. 1.5 mm. and 0.0 mm., respectively, following cinchamidine.
COMMENT Evaluation and Significance of Results
The above studies illustrate the importance of adequate control studies in measuring the value of treatment in angina pectoris, and also the advisability of comparing the effect of the drug under study with the effects of other medication of accepted or potential value. By this means we can clearly demonstrate the contrast between the negative results obtained with three of the preparations (placebos, procaine amide, and chlorguanide), the moderately favorable results with two drugs (cinchonine and pentaerythritol tetranitrate) and the positive results obtained with seven other drugs (nitroglycerin, quinidine, quinine, cinchonidine, cinchamidine, chloroquine and pentaquine); this contrast emphasizes the significance of the results with the latter seven drugs.
These studies also illustrate the value of considering separately the results obtained in patients likely to respond to medication and in those not likely to react favorably. Thus, of the 16 patients who showed a marked response to nitroglycerin, nine showed a marked response and six more showed a moderate response to one or more of the cinchona alkaloids. Similarly, of the seven patients who showed a moderate response to nitroglycerin, six showed a moderate response to other drugs. In contrast, only two of the nine patients who showed no response to nitroglycerin showed a moderate response to other drugs. In our experience, the frequency of group 3 patients has varied from 28 per cent of the subjects in the present study to 40 per cent in previous studies with larger numbers of subjects.26 Unless the negative results in these nonreacting patients are separated from the results obtained in patients more likely to respond to medication, the beneficial results in the latter group are likely to be overlooked or minimized because of dilution with negative results.
It is advisable to compare the efficacy of the cinchona alkaloids with that of other therapy used in angina. From the results of the above and also from the results of previous studies, nitroglycerin ranks highest in the frequency and the magnitude of its prophylactic effect in angina pectoris; its practical value is limited, however, by its relatively short duration of action.2 Pentaerythritol tetranitrate is obviously of some value in some patients, but it is much less effective than other available drugs including some of the cinchona alkaloids. Comparison with previous studies indicates that the effectiveness of the cinchona alkaloids is of the same magnitude as that of nonenteric coated theobromine sodium acetate and aminophylline in appropriate doses15 and is considerably greater than that of oral papaverine21 or khellin. 30 The cinchona alkaloids rank, therefore, among the most effective of medicinal agents available for the treatment of angina pectoris.
Mechanism of Action
The pharmacologic action of the cinchona alkaloids is incompletely understood even in the treatment of malaria in which it has been used for centuries It is probable that the cinchona alkaloids owe their effectiveness in angina pectoris to the presence of the quinoline ring ( fig. 1 ). This would explain why chloroquine and pentaquine are also effective while chlorguanide, which has a phenol rather than a quinoline ring, is of no value. In this regard, it is of interest to note that papaverine, ethaverine, and pavril also contain the quinoline ring and are also of value in angina pectoris although the latter three are much less effective in angina pectoris than are the cinchona alkaloids.2'
The quinoline nucleus, together with many of its derivatives, possesses varied pharmacologic activity inducing antiseptic, anesthetic, and circulatory effects and a depressant action on the nerve endings. [31] [32] [33] [34] Advantage is taken of these properties in therapeutics. The antiseptic properties are employed in preservatives (e.g., chinosol), amebicides (e.g., Vioform) and antimalarials (e.g., quinine). The anesthetic effects are seen with some qulilninie salts and especially Nupercaine. The circulatory effects have been incompletely studied, but include slowing of the heart, increase in the refractory period and vasodilation which is antagonistic to the action of epinephrine.33' 34 The effect on the nerve endings has been suggested as the mode of action of quinine and quiniidine in night cramps.35 36 The many quinoline derivatives each possess all of these activities in varying degrees although one effect may outbalance the others so as to seem quite specific. Thus quinidilne is much more effective in the treatment of arrhythmias than the other cinchona alkaloids, and cinchonine is less effective in angina pectoris. Quinoline itself (as 8-hydroxy- quinolinie sulfate) has been found to be of slight value in angina pectoris.11
The possible roles of other mechanisms in achieving therapeutic results in angina pectoris deserve comment. Quinidine and also procaine amide have been advocated for the treatment of angina pectoris where exertion induces ventricular premature beats.', 5 6 It is unlikely that the beneficial results observed in the present series are due to this action, for few of the patients developed premature beats on exertion or during attacks, and procaine amide was not found of value in the present group. Furthermore, it has been shown that in the treatment of arrythmias (auricular fibrillation, for example), quinidine is far more effective than are quinine, cinchonidine, or cinchamidine,8' 9whereas in angina pectoris these drugs are almost equal in value.
The similarity of the clinical effectiveness of quinine and quinidine in both angina pectoris and in night cramps (which are not infrequent in patients with angina) is of interest. It is presumed that in night cramps the cinchona alkaloids act by blocking the nerve impulses at the myoneural junction.35 36 The evidence that this is the sole mode of action is far from conclusive, however, and the possibility of other pharmacologic activity which may be of value in both conditions, deserves further study.
Toxic and Untoward Effects
The potential toxicity, as well as the usual safety of the cinchona alkaloids is well known owing to their widespread use in the treatment of malaria. For convenience, the undesired reactions may be divided into A, the toxic or more serious effects, and B, the untoward or less serious effects.
A. Toxic Effects. These No toxic and few untoward effects were observed.
Quinidine and quinine are among the most effective of the drugs now available for the treatment of angina pectoris.
3. Quinine is the drug of choice because of low toxicity, effectiveness, and low cost to the patient. Quinine possesses little of the potential cardiotoxic effects of quinidine. The latter drug is equally available but somewhat higher in cost. Quinidine is possibly somewhat more effective in angina than is quinine. 4 . The effectiveniess of the (cinchonia alkaloids in angina pectoris is due, at least in part, to a vasodilator action. The quiinolinie ring is probably the portion of the molecule primarily responsible for the therapeutic effect. 4. La efectividad de los alkaloides de cinchona en la angina de pecho se debe, por lo menos en parte, a acci6n vasodilatadora. El anillo de quinolina es probablemente la porcion de la molecula primariamente responsable por su efecto terapeuitico.
